Author information: (1)MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom. (2)Population Health Sciences, Bristol Medical School, Bristol, United Kingdom. (3)Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, United Kingdom. (4)Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, United States. (5)Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom. (6)Department of Hygiene and Epidemiology, School of Medicine, University of Ioannina, Ioannina, Greece. (7)Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, United States. (8)Department of Epidemiology, School of Public Health, University of Washington, Seattle, United States. (9)Department of Clinical Pathology, Melbourne Medical School, University of Melbourne, Parkville, Australia. (10)Cancer Prevention Institute of California, Fremont, United States. (11)The Institute of Cancer Research, London, United Kingdom. (12)Royal Marsden NHS Foundation Trust, London, United Kingdom. (13)Center for Genetic Epidemiology, Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, United States. (14)Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, United States. (15)Seidman Cancer Center, University Hospitals, Cleveland, United States. (16)Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom. (17)University of Cambridge, Department of Clinical Neurosciences, Stroke Research Group, Cambridge, United Kingdom. (18)Division of Population Health, Health Services Research and Primary Care, University of Manchester, Manchester, United Kingdom. (19)Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, United States. (20)Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden. (21)Department of Population Science, American Cancer Society, Atlanta, United States. (22)SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, United States. (23)Australian Prostate Cancer Research Centre-Qld, Institute of Health and Biomedical Innovation and School of Biomedical Sciences, Queensland University of Technology, Brisbane, Australia. (24)Translational Research Institute, Brisbane, Australia. (25)Australian Prostate Cancer Research Centre-Qld, Queensland University of Technology, Brisbane; Prostate Cancer Research Program, Monash University, Melbourne; Dame Roma Mitchell Cancer Centre, University of Adelaide, Adelaide, Australia. (26)Department of Applied Health Research, University College London, London, United Kingdom. (27)Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Strangeways Laboratory, Worts Causeway, Cambridge, United Kingdom. (28)Institute of Biomedicine, University of Turku, Turku, Finland. (29)Department of Medical Genetics, Genomics, Laboratory Division, Turku University Hospital, Turku, Finland. (30)Department of Surgical Sciences, Uppsala University, Uppsala, Sweden. (31)Division of Cancer Sciences, University of Manchester, Manchester Academic Health Science Centre, Radiotherapy Related Research, The Christie Hospital NHS Foundation Trust, Manchester, United Kingdom. (32)Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, United States. (33)CeRePP, Tenon Hospital, Paris, France. (34)Sorbonne Universite, GRC n°5 , AP-HP, Tenon Hospital, 4 rue de la Chine, Paris, France. (35)Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark. (36)Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. (37)Department of Medical Genetics, Oslo University Hospital, Oslo, Norway. (38)Nuffield Department of Surgical Sciences, University of Oxford, Room 6603, Level 6, John Radcliffe Hospital, Headley Way, Oxford, United Kingdom. (39)University of Cambridge, Department of Oncology, Cambridge, United Kingdom. (40)Cancer Research UK, Cambridge Research Institute, Cambridge, United Kingdom. (41)Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom. (42)Faculty of Medical Science, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom. (43)Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom. (44)Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom. (45)Dept. of Surgical Oncology, Princess Margaret Cancer Centre, Toronto, Canada. (46)Dept. of Surgery (Urology), University of Toronto, Toronto, Canada. (47)Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, United States. (48)Department of Radiation Oncology and Department of Genetics and Genomic Sciences, Box 1236, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, United States. (49)Centre for Cancer Biomarker and Biotherapeutics, Barts Cancer Institute, Queen Mary University of London, John Vane Science Centre, Charterhouse Square, London, United Kingdom. (50)Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia. (51)Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Australia. (52)Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Victoria, Australia. (53)Division of Urologic Surgery, Brigham and Womens Hospital, Boston, United States. (54)Fundación Pública Galega Medicina Xenómica, Santiago de Compostela, Spain. (55)Instituto de Investigación Sanitaria de Santiago de Compostela, Santiago De Compostela, Spain. (56)Centro de Investigación en Red de Enfermedades Raras (CIBERER), Valencia, Spain. (57)ISGlobal, Barcelona, Spain. (58)IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain. (59)Universitat Pompeu Fabra (UPF), Barcelona, Spain. (60)CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. (61)Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital/Harvard Medical School, Boston, United States. (62)Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, United States. (63)Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, United States. (64)International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. (65)Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. (66)Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. (67)Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. (68)German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. (69)Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany. (70)Humangenetik Tuebingen, Tuebingen, Germany. (71)The University of Texas M. D. Anderson Cancer Center, Department of Genitourinary Medical Oncology, Houston, United States. (72)Departments of Epidemiology & Population Health and of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, United States. (73)Department of Genetics, Portuguese Oncology Institute of Porto (IPO-Porto), Porto, Portugal. (74)Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal. (75)Cancer Genetics Group, IPO-Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO-Porto), Porto, Portugal. (76)Department of Population Sciences, Beckman Research Institute of the City of Hope, Duarte, United States. (77)Ghent University, Faculty of Medicine and Health Sciences, Basic Medical Sciences, Ghent, Belgium. (78)Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. (79)Department of Urology, University of Washington, Seattle, United States. (80)Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. (81)Molecular Medicine Center, Department of Medical Chemistry and Biochemistry, Medical University of Sofia, Sofia, Bulgaria. (82)Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Canada. (83)Division of Radiation Oncology, Cross Cancer Institute, University Avenue, Edmonton, Canada. (84)Molecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine, Leuven, Belgium. (85)Division of Cancer Sciences, Manchester Cancer Research Centre, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Health Innovation Manchester, Univeristy of Manchester, Manchester, United Kingdom. (86)The University of Surrey, Guildford, Surrey, United Kingdom. (87)Genetic Oncology Unit, CHUVI Hospital, Complexo Hospitalario Universitario de Vigo, Instituto de Investigación Biomédica Galicia Sur (IISGS), Vigo, Spain. (88)Department of Urology, Erasmus University Medical Center, Rotterdam, Netherlands. (89)"Exposome and Heredity", CESP (UMR 1018), Faculté de Médecine, Université Paris-Saclay, Villejuif, France. (90)Clinical Gerontology Unit, University of Cambridge, Cambridge, United Kingdom. (91)Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, United States. (92)George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, United States. (93)Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, United States. (94)Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom. (95)Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard School of Public Health, Boston, United States. (96)Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, United States. (97)International Epidemiology Institute, Rockville, United States. (98)National Institute for Health Research (NIHR) Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol, Bristol, United Kingdom. (99)Department of Biostatistics, Fielding School of Public Health, University of California, Los Angeles, Los Angeles, United States. (100)Novo Nordisk Research Centre, Oxford, United Kingdom.